A bill to amend titles XI and XVIII of the Social Security Act to provide greater transparency of discounts provided by drug manufacturers, to establish requirements relating to pharmacy-negotiated price concessions, and for other purposes.
About This Bill
Committee
Latest Action · July 24, 2019
Read twice and referred to the Committee on Finance.